# Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

> **NCT05764317** · — · COMPLETED · sponsor: **Servier Russia** · enrollment: 409 (actual)

## Conditions studied

- Arterial Hypertension
- HTN

## Interventions

- **DRUG:** Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg
- **DRUG:** Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 5 mg
- **DRUG:** Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 10 mg

## Key facts

- **NCT ID:** NCT05764317
- **Lead sponsor:** Servier Russia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-30
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-02-20
- **Target enrollment:** 409 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764317, "Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05764317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*